Inventor · disambiguated record
Laleh Majlessi
Also filed as: MAJLESSI LALEH
4 granted patents·9 pending applications·8 citations·filing 2003–2023
66Inventor score
Files withPASTEUR INSTITUT6LECLERC CLAUDE3BROSCH ROLAND1COLE STEWART1INST PASTEUR INSERM I NAT DE L1
Top patents by PatentIndex Score
13 records- 0175US8747866B2Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microtiCOLE STEWART·Filed 2010·Granted Jun 10, 2014·5 cites·48 claims
- 0268US8398991B2Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCGBROSCH ROLAND·Filed 2006·Granted Mar 19, 2013·2 cites·10 claims
- 0365US7883712B2Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microtiPASTEUR INSTITUT·Filed 2003·Granted Feb 8, 2011·1 cites·18 claims
- 0460US2025090655A1Boosting sars-cov-2 immunity with a lentiviral-based nasal vaccinePASTEUR INSTITUT·Filed 2023·Application pending·0 cites
- 0557US2024415951A1Lentiviral vector for expression of human papillomavirus (hpv) antigens and its implementation in the treatment of hpv induced cancersTHERAVECTYS·Filed 2022·Application pending·0 cites
- 0654US2025319173A1Lentiviral vectors targeting antigens to mhc-ii pathway and inducing protective cd8+ and cd4+ t-cell immunity in a hostPASTEUR INSTITUT·Filed 2022·Application pending·0 cites
- 0750US2023364216A1Lentiviral vectors enabling routing antigens to mhc-ii pathway and inducing cd4+ and cd8+ t-cell responses in a hostPASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 0849US2023256084A1Sars-cov-2 immunogenic compositions, vaccines, and methodsPASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 0946US2009317854A1Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseINST PASTEUR INSERM I NAT DE L·Filed 2008·Application pending·0 cites
- 1042US2006286613A1Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseLECLERC CLAUDE·Filed 2006·Application pending·0 cites
- 1140US2013121958A1Streptavidin and biotin-based antigen delivery systemLECLERC CLAUDE·Filed 2010·Application pending·0 cites
- 1238US2006019323A1Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseLECLERC CLAUDE·Filed 2004·Application pending·0 cites
- 1332US10010597B2Recombinant Mycobacterium bovis BCG expressing antigens of the Mycobacterium marinum ESX-1 secretion systemPASTEUR INSTITUT·Filed 2015·Granted Jul 3, 2018·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →